An open study with reversible MAO-A inhibitors in complicated Parkinson's disease.

Advances in neurology

Volumn 69, Issue , 1996, Pages 595-598

  Ruggieri, S ^a   Fabbrini, G ^a   Bramante, L ^a   DePandis, F ^a   Stocchi, F ^a   Barbanti, P ^a   Vacca, L ^a   Manfredi, M ^a  

^a Mediterranean Institute of Neuroscience   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; BENZAMIDE DERIVATIVE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR;

ARTICLE; CLINICAL TRIAL; DRUG COMBINATION; HUMAN; MIDDLE AGED; MOTOR DYSFUNCTION; PARKINSON DISEASE;

ANTIPARKINSON AGENTS; BENZAMIDES; DOPAMINE AGONISTS; DRUG THERAPY, COMBINATION; HUMANS; LEVODOPA; MIDDLE AGED; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITORS; MOVEMENT DISORDERS; PARKINSON DISEASE;

EID: 0029690729     PISSN: 00913952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)